ArticleEuropean urology oncology2025

Presence of an Artificial Intelligence-powered Predictive Biomarker Is Associated with a Poor Response to Intravesical Bacillus Calmette-Guerin but Not to Intravesical Sequential Gemcitabine/Docetaxel in Patients with High-grade Non-muscle-invasive Bladder Cancer.

Vignesh T Packiam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.